Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial
Clinical trial NCT00310375 · COMPLETED
Trial details
- NCT number
- NCT00310375
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2016-11-30
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.